CORD-19:ceba28d8304f3df8001164f8edeef545154289f6 / 36699-36859 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/ceba28d8304f3df8001164f8edeef545154289f6","sourcedb":"CORD-19","sourceid":"ceba28d8304f3df8001164f8edeef545154289f6","text":"Studies are ongoing to define anti-MuPyV effector mechanism(s) in the CNS and potential preferential expression of effector activities by antiviral CD8 T cells.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T209","span":{"begin":0,"end":160},"obj":"Sentence"},{"id":"TextSentencer_T209","span":{"begin":0,"end":160},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T209","pred":"source","obj":"CORD-19-Sentences"},{"subj":"TextSentencer_T209","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T111","span":{"begin":70,"end":73},"obj":"Body_part"}],"attributes":[{"id":"A111","pred":"uberon_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"subj":"T111","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#c293ec","default":true},{"id":"CORD-19-PD-UBERON","color":"#93eca8"}]}]}}